ARTICLE | Company News
Takeda, Abbott receive European approval
May 29, 2001 7:00 AM UTC
Takeda (Osaka, Japan) received marketing authorization from the European Commission for Ixense apomorphine sublingual tablet to treat erectile dysfunction (ED). The MAA was submitted in November 1999....